Active	Status	Sponsor type	Region	Phase	Filter
1 Active 11 Inactive 12 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Durán, Leopoldo Baiza
PRO-165, NCT03697876: Safety and Tolerability of the Ophthalmic Gel Versus Artelac® Nightime Gel	Completed	1	32	RoW	PRO-165, sodium hyaluronate 0.2%, chondroitin sulfate + sodium hyaluronate, chondroitin sulfate 0.18%, Artelac, Carbomer 0.2%	Laboratorios Sophia S.A de C.V.	Dry Eye Syndromes	06/24	06/24